drug
as of 2026-07-01Blood sampling
blood sampling
at a glance
BIOLOGICAL
Pre-approval / investigational in the US
Developed by Anders Fink-Jensen, MD, DMSci
6 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BIOLOGICAL
Indications
Investigational (via trials)
Trials
6
Immuno-Genetic, Inflammation, Retro-Virus, Environment
NCT02878408—Recruiting
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
NCT06304233—Active Not Recruiting
COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark
NCT04775407—Terminated
Psychosis-Associated Neuroinflammation in Schizophrenia
NCT02009826—Completed
Screening of Niemann-Pick Disease, Type C in a Psychiatric Population
NCT02841358—Terminated
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
NCT02625103Phase 4Completed
KOLs & investigators
4
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Anders Fink-Jensen, MD, professor, DMSci.
personKOL score 5
Morten A Høydal, PhD
personKOL score —
Bernard Sabbe, MD PhD
personKOL score —
Claire Buis, Doctor
personKOL score —